FindTrial
Sign In

Prospective observational study to evaluate the effect of supercritical carbon dioxide processed acellular dermal matrix(SC DERM® Recon) in prosthetic breast reconstruction

Prospective observational study to evaluate the effect of supercritical carbon dioxide processed acellular dermal matrix(SC DERM® Recon) in prosthetic breast reconstruction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008722
Enrollment
50
Registered
2023-08-18
Start date
2023-06-12
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients between the ages of 20 and 80 who are undergoing immediate breast reconstruction using implants after total mastectomy

Exclusion criteria

Exclusion criteria: 1) Patients who have undergone organ transplantation and are taking immunosuppressants 2) A person whose mental condition may affect the progress of the clinical trial due to alcohol or drug abuse, etc. 3) Those who are unable to conduct the survey conducted in this clinical trial 4) Those who participated in other clinical trials within 120 days before screening 5) If other investigators judge that it is inappropriate for this clinical trial

Design outcomes

Primary

MeasureTime frame
Complication Rate—

Secondary

MeasureTime frame
BREAST-Q Assessment—

Countries

Korea, Republic of

Contacts

Public ContactHyun Han

Asan Medical Center

tripleh1952@gmail.com+82-2-3010-5914

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026